Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K050100Substantially Equivalent

Rna1c Hemoglobin A1c Control for Bayer Dca2000 and Dca2000+ Analyzer

Bionostics, Inc., Devens MA / Traditional, Substantially Equivalent

K050100 is the FDA 510(k) clearance record for RNA1C HEMOGLOBIN A1C CONTROL FOR BAYER DCA2000 AND DCA2000+ ANALYZER, a class I device, cleared for Bionostics, Inc. on under FDA product code JJX (Single (Specified) Analyte Controls (Assayed And Unassayed)). FDA records list 49 510(k) clearances for Bionostics, Inc., from to . As of , FDA records show no recalls naming K050100.

Clearance record

Decision date
Received
(38 days to decision)
Product code
JJX Single (Specified) Analyte Controls (Assayed And Unassayed)
Regulation
21 CFR 862.1660
Device class
Class I
Review panel
Clinical Chemistry
Applicant
Bionostics, Inc. 7 Jackson Rd., Devens MA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code JJX

Trailing 12 months

FDA records hold no clearances under product code JJX in the trailing twelve months.

FDA records show no clearances under product code JJX in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code JJX, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260